Pharmacokinetics (PK) and tolerability of single and multiple doses of bosentan, an oral dual endothlein receptor antagonist, in children with pulmonary arterial hypertension

被引：0
|
作者：
Barst, RJ
Ivy, D
Widlitz, AC
Moore, K
Doran, A
van Giersbergen, P
Nguyen, N
Gaitonde, MD
机构：
[1] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[2] Univ Colorado, Childrens Hosp, Denver, CO 80202 USA
[3] Actelion Pharmaceut Ltd, Allschwil, Switzerland
来源：
CIRCULATION | 2002年 / 106卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2239
引用
收藏
页码：450 / 450
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and safety of bosentan, an oral dual endothelin receptor antagonist in children with pulmonary arterial hypertension: BREATHE-3
    Barst, R
    Ivy, D
    Widlitz, AC
    Moore, K
    Doran, A
    Nguyen, N
    Gaitonde, MD
    EUROPEAN HEART JOURNAL, 2002, 23 : 489 - 489
  • [2] Effects of the oral endothelin receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension
    Galie, N
    Hinderliter, AL
    Torbicki, A
    Simonneau, G
    Espinola-Zabaleta, N
    Rocchi, G
    Kurzyna, M
    Kronenberg, A
    Frantz, R
    Sherif, N
    Barst, R
    Dujardin, K
    Channick, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 224A - 224A
  • [3] Pharmacokinetics and preliminary safety data of a single oral dose of bosentan, a dual endothelin receptor antagonist, in cats
    Puza, N.
    Papich, M. G.
    Reinero, C.
    Chang, C. -H.
    Yu, D. -H.
    Sharp, C.
    DeClue, A.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2014, 37 (02) : 192 - 195
  • [4] Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension
    Galiè, N
    Hinderliter, AL
    Torbicki, A
    Fourme, T
    Simonneau, G
    Pulido, T
    Espinola-Zavaleta, N
    Rocchi, G
    Manes, A
    Frantz, R
    Kurzyna, M
    Nagueh, SF
    Barst, R
    Channick, R
    Dujardin, K
    Kronenberg, A
    Leconte, I
    Rainisio, M
    Rubin, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (08) : 1380 - 1386
  • [5] Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension
    Hopper, Rachel K.
    Ivy, D. Dunbar
    Yung, Delphine
    Mullen, Mary P.
    Hanna, Brian D.
    Kirkpatrick, Edward
    Hirsch, Russel
    Austin, Eric D.
    Fineman, Jeffrey
    Solum, Derek
    Deng, C. Q.
    Feinstein, Jeffrey A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (01) : 94 - 100
  • [6] The remodeling of connexin in the hypertrophied right ventricular in pulmonary arterial hypertension and the effect of a dual ET receptor antagonist (bosentan)
    Tan, Xiao-Yan
    He, Han-Guo
    PATHOLOGY RESEARCH AND PRACTICE, 2009, 205 (07) : 473 - 482
  • [7] Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan
    Beghetti, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 16 - 24
  • [8] Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers
    Weber, C
    Schmitt, R
    Birnboeck, H
    Hopfgartner, G
    Eggers, H
    Meyer, J
    van Marle, S
    Viischer, HW
    Jonkman, JHG
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (07): : 703 - 714
  • [9] Complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension
    Badesch, DB
    Bodin, F
    Channick, RN
    Frost, A
    Rainisio, M
    Robbins, IM
    Roux, S
    Rubin, LJ
    Simonneau, G
    Sitbon, O
    Tapson, VF
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (04): : 227 - 246
  • [10] Treatment of pulmonary arterial hypertension with macitentan, dual endothelin receptor antagonist
    Bichara, Valentina M.
    Bevacqua, Raul J.
    INSUFICIENCIA CARDIACA, 2019, 14 (03) : 119 - 128
12345